An in-depth look to ALDEYRA THERAPEUT.DL-,001 operating, investing, and financing activities

137 free cash flow for Q3 24 is -7.16 M EUR. For 2023, 137 free cash flow was -27.48 M EUR and operating cash flow was -27.48 M EUR.